GlassScriptPhysician profile
Robert N Aguillard
NPI 1659362960
$11,407.54
in general payments reported to CMS, 2019-2025
47 companies · $2,203 in 2025
The $2,203 reported for 2025 was more than what 88% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,141 · 2020: $1,201 · 2021: $1,825 · 2022: $1,440 · 2023: $1,556 · 2024: $2,042 · 2025: $2,203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,685 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,684.96 |
| Education | $116.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,706.80 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,607.67 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| United Therapeutics Corporation | $958.13 | 2020-2025 | Tyvaso, Tyvaso, Orenitram |
| Harmony Biosciences LLC | $873.68 | 2021-2025 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $866.28 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Genentech USA, INC. | $734.79 | 2019-2025 | Xolair |
| Insmed, INC. | $576.43 | 2019-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $404.70 | 2021-2025 | |
| Mylan Specialty L.P. | $370.70 | 2019-2024 | Yupelri |
| Grifols USA, LLC | $236.11 | 2019-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $235.26 | 2020-2025 | Uptravi, Opsumit, Opsynvi |
| Philips North America LLC | $217.58 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $207.85 | 2019-2025 | Zerbaxa, Recarbrio, Keytruda |
| Regeneron Healthcare Solutions, INC. | $201.59 | 2021-2025 | Dupixent |
| La Jolla Pharmaceutical Company | $168.30 | 2021-2022 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $167.55 | 2021-2025 | Glassia |
| Verona Pharma, INC. | $137.17 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $129.35 | 2019-2020 | |
| Electromed, INC. | $127.81 | 2024-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $117.02 | 2020-2024 | |
| Zoll Respicardia, INC. | $112.26 | 2022-2024 | Remede System |
| Abbvie INC. | $96.64 | 2021-2024 | |
| Amgen INC. | $96.31 | 2024-2025 | Tezspire |
| Mallinckrodt Hospital Products INC. | $81.54 | 2020-2021 | |
| Tetraphase Pharmaceuticals, INC. | $77.52 | 2019-2020 | |
| Pfizer INC. | $75.23 | 2019-2022 | |
| Lilly USA, LLC | $63.66 | 2025 | Zepbound |
| Mallinckrodt Enterprises LLC | $63.42 | 2019 | |
| Arbor Pharmaceuticals, INC. | $56.42 | 2021 | |
| Bioxcel Therapeutics, INC. | $54.49 | 2023 | Igalmi |
| Fisher & Paykel Healthcare INC | $52.33 | 2020-2025 | Fisher & Paykel Healthcare |
| Allergan, INC. | $52.12 | 2019-2020 | |
| Caris Mpi, INC. | $47.34 | 2025 | Mi Cancer Seek |
| Viatris Specialty LLC | $45.42 | 2025 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $43.50 | 2023 | |
| Gilead Sciences, INC. | $42.03 | 2021 | |
| Jazz Pharmaceuticals INC. | $41.96 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $41.77 | 2022 | |
| Csl Behring | $39.82 | 2019 | |
| Tactile Systems Technology INC | $35.86 | 2024 | Flexitouch Plus, Entre Plus |
| Baxter Healthcare | $35.83 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Advanced Respiratory, INC | $31.16 | 2020-2021 | |
| Cumberland Pharmaceuticals, INC. | $26.37 | 2020-2021 | |
| Pulmonx Corporation | $21.60 | 2024 | Zephyr Delivery Catheter, Chartis Catheter, Zephyr Endobronchial Valve |
| Boston Scientific Corporation | $12.62 | 2022 | |
| Ambu INC. | $8.25 | 2022 | |
| Veran Medical Technologies, INC. | $7.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Aguillard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.